These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22419225)

  • 1. What matters in measuring methamphetamine-related cognitive impairments: 'abnormality detection' versus 'everyday import'?
    Payer DE; Dean AC; Boileau I
    Neuropsychopharmacology; 2012 Apr; 37(5):1081-2. PubMed ID: 22419225
    [No Abstract]   [Full Text] [Related]  

  • 2. Is cognitive functioning impaired in methamphetamine users? A critical review.
    Hart CL; Marvin CB; Silver R; Smith EE
    Neuropsychopharmacology; 2012 Feb; 37(3):586-608. PubMed ID: 22089317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance of current methamphetamine and cocaine abusers.
    Simon SL; Domier CP; Sim T; Richardson K; Rawson RA; Ling W
    J Addict Dis; 2002; 21(1):61-74. PubMed ID: 11831501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of relapse on cognition in abstinent methamphetamine abusers.
    Simon SL; Dacey J; Glynn S; Rawson R; Ling W
    J Subst Abuse Treat; 2004 Jul; 27(1):59-66. PubMed ID: 15223095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of cognitive performance by topiramate: Blockage of automatic processes may be the underlying mechanism.
    Zullino DF; Benguettat D; Khazaal Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):787. PubMed ID: 17291662
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of longitudinal changes in cognition in individuals with methamphetamine use disorder during the first 6 weeks after commencing treatment.
    Fitzpatrick RE; Robinson AH; Rubenis AJ; Lubman DI; Verdejo-Garcia A
    Am J Drug Alcohol Abuse; 2021 May; 47(3):383-392. PubMed ID: 33524275
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers.
    Hosak L; Preiss M; Bazant J; Tibenska A; Cermakova R; Cermakova E
    Psychiatr Danub; 2012 Jun; 24(2):188-93. PubMed ID: 22706418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
    van Gorp WG; Hinkin CH
    Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716
    [No Abstract]   [Full Text] [Related]  

  • 9. Methamphetamine-induced neural and cognitive changes in rodents.
    Marshall JF; Belcher AM; Feinstein EM; O'Dell SJ
    Addiction; 2007 Apr; 102 Suppl 1():61-9. PubMed ID: 17493054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
    Harro J
    Int Rev Neurobiol; 2015; 120():179-204. PubMed ID: 26070758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
    Stock AK; Beste C
    Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):123-30. PubMed ID: 16978753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness.
    Dean AC; Morales AM; Hellemann G; London ED
    Neuropsychopharmacology; 2018 Jul; 43(8):1745-1752. PubMed ID: 29704001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence.
    Proebstl L; Krause D; Kamp F; Hager L; Manz K; Schacht-Jablonowsky M; Straif M; Riebschläger M; Neumann S; Schreiber A; Soyka M; Koller G
    Psychiatry Res; 2019 Nov; 281():112599. PubMed ID: 31629302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticolimbic dysregulation and chronic methamphetamine abuse.
    Baicy K; London ED
    Addiction; 2007 Apr; 102 Suppl 1():5-15. PubMed ID: 17493049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence.
    Simon SL; Dean AC; Cordova X; Monterosso JR; London ED
    J Stud Alcohol Drugs; 2010 May; 71(3):335-44. PubMed ID: 20409426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.
    Kalechstein AD; Yoon JH; Croft DE; Jaeggi S; Mahoney JJ; De La Garza R
    Pharmacol Biochem Behav; 2011 Sep; 99(3):423-7. PubMed ID: 21624391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological comparisons of cocaine versus methamphetamine users: A research synthesis and meta-analysis.
    Hall MG; Hauson AO; Wollman SC; Allen KE; Connors EJ; Stern MJ; Kimmel CL; Stephan RA; Sarkissians S; Barlet BD; Grant I
    Am J Drug Alcohol Abuse; 2018; 44(3):277-293. PubMed ID: 28825847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
    Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
    Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.